LifeStance Health Group, Inc. is 1.9x more valuable than GeneDx Holdings Corp. by market capitalization ($3.05 B vs $1.61 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | WGS | LFST |
|---|---|---|
| Market cap | $1.61 B | $3.05 B |
| US-listed rank | #2259 | #1787 |
| Revenue (latest FY) | $427.54M | $1.42B |
| Net income (latest FY) | -$21.00M | $9.66M |
| Net margin | -4.9% | 0.7% |
| P/E (trailing FY) | - | 315.5 |
| SEC filings | 748 | 452 |
LifeStance Health Group, Inc. is 1.9x more valuable than GeneDx Holdings Corp. by market capitalization ($3.05 B vs $1.61 B).
In their latest fiscal years, GeneDx Holdings Corp. reported $427.54M in revenue while LifeStance Health Group, Inc. reported $1.42B.
Full pages: GeneDx Holdings Corp. and LifeStance Health Group, Inc., or browse the full rankings.